Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ascendis Pharma A (ASND) Other Non-Current Assets: 2012-2025

Historic Other Non-Current Assets for Ascendis Pharma A (ASND) over the last 11 years, with Jun 2025 value amounting to $559.2 million.

  • Ascendis Pharma A's Other Non-Current Assets rose 100.74% to $559.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $559.2 million, marking a year-over-year increase of 100.74%. This contributed to the annual value of $605.6 million for FY2024, which is 43.53% up from last year.
  • Per Ascendis Pharma A's latest filing, its Other Non-Current Assets stood at $559.2 million for Q2 2025, which was up 2.65% from $544.8 million recorded in Q1 2025.
  • Over the past 5 years, Ascendis Pharma A's Other Non-Current Assets peaked at $846.8 million during Q1 2022, and registered a low of $278.6 million during Q2 2024.
  • Over the past 3 years, Ascendis Pharma A's median Other Non-Current Assets value was $509.2 million (recorded in 2023), while the average stood at $488.5 million.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first spiked by 149.36% in 2021, then crashed by 39.98% in 2023.
  • Quarterly analysis of 5 years shows Ascendis Pharma A's Other Non-Current Assets stood at $505.3 million in 2021, then dropped by 13.63% to $436.5 million in 2022, then fell by 3.33% to $421.9 million in 2023, then soared by 41.71% to $597.9 million in 2024, then spiked by 100.74% to $559.2 million in 2025.
  • Its Other Non-Current Assets stands at $559.2 million for Q2 2025, versus $544.8 million for Q1 2025 and $597.9 million for Q4 2024.